|
BMPR1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54321000422897E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.79216707719388E-14 |
| Normal-vs-Stage2 |
5.58442181386454E-14 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.926400E-01 |
| Stage1-vs-Stage3 |
3.480200E-01 |
| Stage1-vs-Stage4 |
1.69139999994794E-06 |
| Stage2-vs-Stage3 |
9.030200E-01 |
| Stage2-vs-Stage4 |
5.324400E-03 |
| Stage3-vs-Stage4 |
2.161800E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.7715611723761E-15 |
| Normal-vs-AfricanAmerican |
9.77300000037928E-07 |
| Normal-vs-Asian |
6.66133814775094E-16 |
| Caucasian-vs-AfricanAmerican |
4.674800E-01 |
| Caucasian-vs-Asian |
1.663010E-01 |
| AfricanAmerican-vs-Asian |
2.208000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63713487211226E-12 |
| Normal-vs-Female |
1.64368518795754E-12 |
| Male-vs-Female |
7.492400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6769918786963E-12 |
| Normal-vs-Age(41-60Yrs) |
1.63313806922361E-12 |
| Normal-vs-Age(61-80Yrs) |
3.65263375101677E-14 |
| Normal-vs-Age(81-100Yrs) |
1.640080E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.148000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.499000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.260400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.267000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.649200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.962200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.664300E-03 |
| Classical-VS-Follicular |
3.666000E-02 |
| Classical-VS-Other |
6.005200E-01 |
| Classical-VS-Normal |
1.00697228333502E-13 |
| Tall-VS-Follicular |
1.594660E-04 |
| Tall-VS-Other |
4.706300E-02 |
| Tall-VS-Normal |
1.62470037423645E-12 |
| Follicular-VS-Other |
7.834400E-01 |
| Follicular-VS-Normal |
1.48990042525554E-10 |
| Other-VS-Normal |
1.781360E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.18554080283684E-14 |
| Normal-vs-N1 |
1.62458935193399E-12 |
| N0-vs-N1 |
6.960600E-03 |
|
|
